Alnylam Pharmaceuticals
ALNY
#660
Rank
โ‚น3.642 T
Marketcap
โ‚น27,283
Share price
0.62%
Change (1 day)
1.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company